“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

Presentation

Publication Date

10-1-2023

Keywords

washington; pmrc

Clinical Institute

Kidney & Diabetes

Comments

59th EASD Annual Meeting

Recommended Citation

Tuttle, Katherine, "“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond" (2023). Articles, Abstracts, and Reports. 8049.
https://digitalcommons.providence.org/publications/8049